Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Maternity
  4. Back
  5. Infections (Maternity)
  6. Parvovirus Guideline (593)
Important: please update your RDS app to version 4.7.3 Details with newsletter below.

Please update your RDS app to v4.7.3

We asked you in January to update to v4.7.2.  After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. 

To update to the latest release:

 On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Right Decision Service newsletter: February 2025

Welcome to the February 2025 update from the RDS team

1.     Next release of RDS

 

A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:

 

  • Fixes to mitigate the recurring glitches with the RDS admin area and the occasional brief user interface outages which have arisen following implementation of the new distributed technology infrastructure in December 2024.

 

  • Capability to embed content from Google calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream into RDS pages.

 

  • Capability to include simple multiplication in RDS calculators.

 

The release will also incorporate a number of small fixes, including:

  • Exporting of form within Medicines Sick Day Guidance in polypharmacy toolkit
  • Links to redundant content appearing in search in some RDS toolkits
  • Inclusion of accordion headers alongside accordion text in search result snippets.
  • Feedback form on mobile app.
  • Internal links on mobile app version of benzo tapering tool

 

We will let you know when the date and time for the new release are confirmed.

 

2.     New RDS developments

There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.

The Benzodiazepine tapering tool (https://rightdecisions.scot.nhs.uk/benzotapering) is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.

3.     Archiving and version control and new RDS Search and Browse interface

Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.

4.     Statistics

At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .

 

5.     Review of content past its review date

We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.

 

6.     Toolkits in development

Some important toolkits in development by the RDS team include:

  • National CVD prevention pathways – due for release end of March 2025.
  • National respiratory pathways, optimal cancer diagnostic pathways and cancer prehabilitation pathways from the Centre for Sustainable Delivery. We will shortly start work on the national cancer referral pathways, first version due for release via RDS around end of June 2025.
  • HIS Quality of Care Review toolkit – currently in final stages of quality assurance.

 

The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.

 

7. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Friday 28th February 12-1 pm
  • Tuesday 11th March 4-5 pm

 

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

 

To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form  - also available in End-user and Provider sections of the RDS Learning and Support area.   If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

Parvovirus Guideline (593)

Warning
Please report any inaccuracies or issues with this guideline using our online form

Parvovirus B19 virus responsible for erythema infectiosum (fifth disease/ slapped cheek syndrome), 50-75% women of reproductive age are immune.

There is no specific treatment or prophylaxis available against B19 infection, but counseling of non-immune mothers and active monitoring of confirmed maternal infections with intervention to correct fetal anemia is likely to decrease mortality. At present there is no vaccine or treatment with immunoglobulin available.

Spread by respiratory droplets or hand to mouth contact. Epidemics can occur spring and mainly affects children. Viraemia occurs 4-14 days after exposure. “Slapped cheek” rash occurs 1-4 days and is associated with appearance of parvovirus B19 IgM antibodies.

Signs and Symptoms, Mild fever, flu like symptoms, slapped cheek rash, arthralgia. Up to 70% of infected pregnant women are asymptomatic.

Fetal Effects of Parvovirus

This can lead to spontaneous miscarriage and stillbirth. Spontaneous loss before 20 weeks is 13% and after 20 weeks is 0.5% 

Incidence of hydrops fetalis is 3%. Positive parvovirus infection in the absence of hydrops or anaemia does not seem to cause long term neurological morbidity. There is no increase in congenital abnormailty. The peak risk is 5 weeks post infection (range 2-12).

Exposure/Infection

If a woman is exposed to or develops signs or symptoms of parvovirus check immunity

  1. Request IgM ( current) and IgG ( past ) antibodies from booking blood virology

Contact Laboratory: 211-0080 (50080)

  1. If not yet had booking bloods then should attend GP ( NOT to attend maternity unit due to risk of infection)
  2. Email/ contact patients named Consultant informing of test, chase result.

IgM appears after 2 weeks and may last 4 months. IgG appears after 3-4 weeks and lasts for life

IgG + means immune  ( previous parvovirus)

IgG – means not immune (susceptible to parvovirus )

IgM + means infected ( has current infection- needs action)

IgM – means not infected ( no current infection) 

Editorial Information

Last reviewed: 12/10/2017

Next review date: 01/10/2022

Author(s): Laurie Anderson.

Version: 2

Approved By: Obstetrics Clinical Governance Group

Document Id: 593

References

SOGC Clinical Practice Guideline 2002
Parvovirus B19 infection NICE-CKS April 2010